InSite, Merck, Novartis, Pfizer ophthalmic news

Novartis' Sandoz Inc. generics unit filed an appeal asking the U.S. Court of Appeals for the Federal Circuit to rehear a 2011 patent infringement suit regarding AzaSite 1% azithromycin

Read the full 295 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE